Ginwa Enterprise (Group) Inc.

Equities

600080

CNE000000QQ8

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
7.12 CNY +1.57% Intraday chart for Ginwa Enterprise (Group) Inc. +5.64% -4.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Ginwa Enterprise Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Ginwa Enterprise Inc.'s Equity Buyback Plan announced on February 21, 2024. CI
Ginwa Enterprise Inc. announces an Equity Buyback for CNY 150 million worth of its shares. CI
Ginwa Enterprise Inc. authorizes a Buyback Plan. CI
Western Investment Group Co., Ltd. completed the acquisition of Ginwa International Hotel Co., Ltd. from Ginwa Enterprise Inc.. CI
Ginwa Enterprise Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Shaanxi Xiangfeng Industrial Development Co., Ltd. completed the acquisition of 8.39% stake in Chongqing Pharmaceutical Group Shaanxi Co. , Ltd. from Ginwa Enterprise Inc.. CI
Shaanxi Xiangfeng Industrial Development Co., Ltd. agreed to acquire 8.39% stake in Chongqing Pharmaceutical Group Shaanxi Co. , Ltd. from Ginwa Enterprise Inc. for CNY 14.18 million. CI
Ginwa Enterprise Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Xinyu Jinyu Enterprise Management Co., Ltd. completed the acquisition of 5.04% stake in Ginwa Enterprise Inc. from Xinyu Xingpeng Tongchuang Enterprise Management Partnership (Limited Partnership). CI
Ginwa Enterprise to Apply For 400 Million Yuan Bank Loan MT
Xinyu Jinyu Enterprise Management Co., Ltd. signed share transfer contract to acquire 5.04% stake in Ginwa Enterprise Inc. from Xinyu Xingpeng Tongchuang Enterprise Management Partnership (Limited Partnership) for CNY 150 million. CI
Western Investment Group Co., Ltd. entered into an Equity Transfer Agreement to acquire Ginwa International Hotel Co., Ltd. from Ginwa Enterprise Inc. for CNY 344.5 million. CI
Ginwa Enterprise Drops Planned 111 Million Yuan Property Purchase MT
Xiangyunhe Juli No. 6 Private Securities Investment Fund, managed by Nanjing Xiangyunhe Investment Management Co., Ltd cancelled the acquisition of a 3.03% stake in Ginwa Enterprise Inc. (SHSE : 600080) from Century Ginwa Co., Ltd. CI
Ginwa Enterprise Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Xiangyunhe Juli No. 6 Private Securities Investment Fund, managed by Nanjing Xiangyunhe Investment Management Co., Ltd agreed to acquire a 3.03% stake in Ginwa Enterprise Inc. from Century Ginwa Co., Ltd. for CNY 96.1 million. CI
Jinbozhu Heju No. 4 Private Securities Investment Fund managed by Nanjing Jinbozhu Asset Management Co., Ltd. agreed to acquire a 5.01% stake in Ginwa Enterprise Inc. from Century Ginwa Co., Ltd. for approximately CNY 160 million. CI
Ginwa Enterprise Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Century Ginwa Retail Shareholders to Vote July 7 on Sale of Entire 8% Stake in Ginwa Enterprise MT
Ginwa Enterprise Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ginwa Enterprise Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Century Ginwa Retail Eyes Divestment of Entire 8% Stake in Ginwa Enterprise MT
Chart Ginwa Enterprise (Group) Inc.
More charts
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 600080 Stock
  4. News Ginwa Enterprise (Group) Inc.
  5. Ginwa Enterprise to Apply For 400 Million Yuan Bank Loan